China Biologic Products Holdings

NASDAQ
CBPO
Stock
Yield per half year: 0%
Dividend yield: 0%
Sector: Healthcare

Reporting China Biologic Products Holdings

Reports

IFRS
Reporting Annual
2016 2017 2018 2019
Financial report link link link link


Capitalization

IFRS
Reporting Annual Quarterly
2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 LTM Average for 5 years CAGR 5
Capitalization, bln $
0.2824 0.4567 0.7501 1.82 3.85 3.01 2.68 4.5 4.57 4.56
Revenue, bln $
0.203 0.243 0.296 0.3412 0.3704 0.4669 0.5037 0.5244 0.5244 0.5244
Net profit, bln $
0.055 0.071 0.089 0.1048 0.0679 0.1281 0.1388 0.1523 0.1523 0.1523
EV, bln $
0.3524 0.7672 1.67 -0.1838 1.96 2.57 4.34 3.9 -0.6753 3.37
EBIT, bln $
0.0811 0.0924 0.1228 0.1351 0.1539 0.1464 0.166 0.1915 0.2141 0.2141
EBITDA, bln $
0.0944 0.1189 0.146 0.1567 0.1488 0.1694 0.1899 0.2226 0.2226 0.2155
OIBDA, bln $
0.1124 0.1264 0.1589 0.19 0.1958 0.2167 0.1875 0.2147 0.2657 0.2657
Book value, bln $
0.1737 0.2447 0.3337 0.4622 0.5982 1.72 1.7 1.98 1.98 1.68
FCF, bln $
0.052 0.072 0.057 0.0723 0.0639 0.0672 0.2049 0.2374 0.2374 0.2374
Operating Cash Flow, bln $
0.0743 0.0935 0.1094 0.1233 0.1022 0.1039 0.2293 0.2585 0.2585 0.2585
Operating profit, bln $
0.087 0.111 0.133 0.1439 0.1359 0.1462 0.1636 0.1954 0.1954 0.1954
Operating expenses, bln $
0.0509 0.0521 0.0574 0.0732 0.109 0.1739 0.1654 0.329 0.1491 0.1491
CAPEX, bln $
0.022 0.022 0.052 0.051 0.0383 0.0367 0.0244 0.021 0.021 0.021


Balance sheet

IFRS
Reporting Annual Quarterly
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 LTM Average for 5 years CAGR 5
Cash, bln $
0.1441 0.0808 0.1449 0.1838 0.2193 0.3389 0.1618 0.6753 0.6753 1.19
Short-Term Investments $
0.0066 0.0637 0.038 0.0229 0.6135 0.7655 0.5178 0.5178
Long-Term Investments $
0.0182 0.0087 0.0106 0.0149 0.0154 0.0275 0.0183
Accounts Receivable $
0.0194 0.0112 0.0173 0.0194 0.0251 0.0339 0.1232 0.1251 0.1003 0.1521
Total Current Assets $
0.2222 0.2643 0.28 0.3691 0.3934 0.5931 1.36 1.3 1.64 1.64
Net assets, bln $
0.2377 0.2121 0.3823 0.3934 0.5931 1.36 1.3 1.64 1.64 2.08
Assets, bln $
0.4038 0.4468 0.5515 0.605 0.8091 2.01 1.94 2.26 2.26 2.26
Short-Term Debt $
0.0014 0.000773 0.0081 0.0042 0.011 0.0079 0.0098 0.0579 0.0022 0.0021
Long-Term Debt $
0.0059 0.0001 0.03 0.04
Liabilities, bln $
0.0536 0.0998 0.1716 0.0845 0.0838 0.1447 0.1653 0.163 0.1777 0.1777
Net debt, bln $
-0.1043 0.0171 -0.1427 -0.1838 -0.2193 -0.3389 -0.1606 -0.6753 -0.6753 -1.19
Debt, bln $
0.0079 0.0398 0.0979 0.0022 0.0021 0 0 0.0012 0 0
Interest Income $
0.0025 0.0078 0.0076 0.0137 0.0213 0.0117
Interest Expense, bln $
0.000254 0.000583 0.000338 0.000558 0.000324 0.000324
Net interest income, bln $
0.0078 0.0076 0.0137 0.0213 0.0117 0.0117
Goodwill $
0.012 0.0094 0.0108 0.0119 0.0236 0.0234 0.0249 0.3136 0.3085 0.3299
Amortization, bln $
0.0076 0.0089 0.0075 0.0077 0.009 0.0127 0.0129 0.0232 0.0262 0.0272
Cost of production, bln $
0.0588 0.0655 0.08 0.1065 0.124 0.1255 0.1468 0.1747 0.1799 0.1799
Inventory $
0.0757 0.0886 0.1013 0.1264 0.1564 0.2096 0.2433 0.2507 0.2615 0.2615


Share

IFRS
Reporting Annual Quarterly
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Average for 5 years CAGR 5
EPS 1.96 2.71 3.27 3.85 2.46 3.25 3.61 3.93 3.93 3.56
Share price 107.52 78.77 75.91 116.38 118.11 119.99 119.99 119.99 119.99 119.99
Number of shares, mln 27 27 28 26 27 27 28 39.36 38.46 38.79
FCF/share 1.6 1.87 2.76 2.11 2.65 2.31 1.71 5.33 6.12 6.12


Efficiency

IFRS
Reporting Annual Quarterly
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average Average for 5 years CAGR 5
ROE, % 25.21 31.53 29.26 24.81 12.81 11.04 8.12 8.28 8.28 7.86 60.35
ROA, % 15.28 16.67 17.42 18.12 9.61 9.09 7.03 7.26 7.26 6.91 6.69
ROIC, % 16.52 25.08 20.3 23.36 28.18 22.61 11.41 9.75 6.98 7.43 12.10
ROS, % 18.34 27.43 27.56 29.04 29.04 29.04 29.04 29.04 29.04 29.04 11.54
ROCE, % 44.59 28.93 28.96 20.58 8.79 10.53 10.09 10.09 0 0 10.81
EBIT margin 50.52 45.64 45.12 39.53 35.56 38.01 40.82 40.83 0 0 16.52
EBITDA margin 48.88 47.77 45.92 40.16 36.28 37.7 42.45 42.45 41.09 41.09 23.24
Net margin 42.7 45.7 44.7 30.71 18.34 27.43 27.56 29.04 29.04 35.3 11.54
Operational efficiency, % 42.18 36.68 31.31 32.49 37.26 37.26 37.26 37.26 37.26 37.26 15.28
Net interest margin, % 11.88 24.47 26.85 29.15 29.34 29.84 17.75 26.77 27.22 27.09 10.01
FCF yield, % 6.81 15.28 11.49 9.55 3.15 1.88 2.12 2.3 5.36 5.33 3.01


Coefficients

IFRS
Reporting Annual Quarterly
2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average Average for 5 years CAGR 5
P/E
15.6 26.2 45.2 29.5 32.01 22.75 32.42 30.05 30.56 31.4 12.11
P/BV
2.2 3.3 8.6 10.3 6.1 3.27 1.58 2.54 2.2 2.3 35.24
P/S
4.1 7.6 13.1 8.8 5.87 6.24 8.93 8.73 8.88 9.1 8.72
P/FCF
47.52 43.76 43.57 43.49 18.66 18.76 19.22 19.22 19.22 19.22 -120.27
E/P
0.0328 0.0331 0.0244 0.0438 0.0363 0.0342 0.0334 0.0334 0.0334 0.0334 0.02
EV/EBIT
12.38 -1.19 -1.5 15.7 22.66 18.25 -3.15 0 0 0 57.55
EV/EBITDA
3.73 6.45 11.81 -1.17 13.15 15.2 22.85 17.52 -3.03 15.65 25.45
EV/S
-0.5386 -0.5922 5.58 8.61 7.45 -1.29 6.42 6.42 6.42 6.42 9.01
EV/FCF
29.34 -2.54 -3.43 38.78 21.18 16.45 -2.84 14.19 14.19 14.19 -57.66
Debt/EBITDA
0.02 0.01 0 0 0.0062 0 0 0 0 0 1.25
Netdebt/EBITDA
-1.17 -1.47 -2 -0.8456 -3.03 -3.03 -5.54 -5.54 -5.54 -5.54 0.24
Debt/Ratio
0.0041 0.0035 0 0 0.000605 0 0 0 0 0 0.23
Debt/Equity
0.0067 0.0045 0 0 0.000691 0 0 0 0 0 5.91
Debt/Net Income
0.0252 0.02 0 0 0.0084 0 0 0 0 0 7.88
PEG
9.96 9.96 358.28
Beta
0.42 0 0 0 -0.1493 0 0 0.59
Altman Index
4.86 2.04 2.37 2.85 2.03 2.03 1.93 1.93 1.93 1.93 15.06


Dividends

IFRS
Reporting Annual Quarterly
2010 2015 2016 2017 2018 2019 2020 2021 2022 2023 LTM Industry average Average for 5 years CAGR 5
Dividend payout, bln
0.0104 0.0188 0.0188
Dividend
0
Dividend yield, %
0 0 0 0 0 0 0 0 0 0 1.33
Dividends / profit, %
33.12 17.93 27.65 0 0 120.57
Dividend coverage ratio
3.06 5.58 3.61 0.76


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual Quarterly
2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 LTM CAGR 5
CAPEX/Revenue, %
15.14 10.84 9.05 17.57 14.95 10.34 7.86 4.85 4.01 4
R&D, bln
0.007 0.0065 0.0095 0.0117 0.0086 0.0086